Jain Global LLC Biocryst Pharmaceuticals Inc Transaction History
Jain Global LLC
- $11.9 Billion
- Q2 2025
A detailed history of Jain Global LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Jain Global LLC holds 240,693 shares of BCRX stock, worth $1.66 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
240,693Holding current value
$1.66 Million% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
311Shares Held
202MCall Options Held
765KPut Options Held
511K-
Vanguard Group Inc Valley Forge, PA21.8MShares$150 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$138 Million0.0% of portfolio
-
State Street Corp Boston, MA9.81MShares$67.7 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.39MShares$64.8 Million6.02% of portfolio
-
Ubs Group Ag5.97MShares$41.2 Million0.01% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.28B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...